Minarik M - Search Results

1

Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC.

Fiala O, Hosek P, Pesek M, Finek J, Racek J, Stehlik P, Sorejs O, Minarik M, Benesova L, Celer A, Nemcova I, Kucera R, Topolcan O. Fiala O, et al. Among authors: minarik m. Anticancer Res. 2017 Nov;37(11):6469-6476. doi: 10.21873/anticanres.12102. Anticancer Res. 2017. PMID: 29061834

2

Parallel optimization and genotyping of multiple single-nucleotide polymorphism markers by sample pooling approach using cycling-gradient CE with multiple injections.

Minarik M, Benesova L, Fantova L, Horacek J, Heracek J, Loukola A. Minarik M, et al. Electrophoresis. 2006 Oct;27(19):3856-63. doi: 10.1002/elps.200600289. Electrophoresis. 2006. PMID: 16972303

3

Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M.

Jancarikova D, Pesek M, Benesova L, Topolcan O, Holubec L Jr, Minarik M. Jancarikova D, et al. Among authors: minarik m. Anticancer Res. 2007 Jul-Aug;27(4A):1879-82. Anticancer Res. 2007. PMID: 17649787 Free article.

4

Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer.

Salek C, Minarikova P, Benesova L, Nosek V, Strnad R, Zavoral M, Minarik M. Salek C, et al. Among authors: minarik m. Anticancer Res. 2009 May;29(5):1803-10. Anticancer Res. 2009. PMID: 19443408 Free article.

5

Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status.

Pesek M, Benesova L, Belsanova B, Mukensnabl P, Bruha F, Minarik M. Pesek M, et al. Among authors: minarik m. Anticancer Res. 2009 Jul;29(7):2767-73. Anticancer Res. 2009. PMID: 19596959 Free article.

6

Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.

Curila K, Benesova L, Penicka M, Minarik M, Zemanek D, Veselka J, Widimsky P, Gregor P. Curila K, et al. Among authors: minarik m. Genet Test Mol Biomarkers. 2009 Oct;13(5):647-50. doi: 10.1089/gtmb.2009.0041. Genet Test Mol Biomarkers. 2009. PMID: 19645627

7

Assembly of a large Y-STR haplotype database for the Czech population and investigation of its substructure.

Zastera J, Roewer L, Willuweit S, Sekerka P, Benesova L, Minarik M. Zastera J, et al. Among authors: minarik m. Forensic Sci Int Genet. 2010 Apr;4(3):e75-8. doi: 10.1016/j.fsigen.2009.06.005. Forensic Sci Int Genet. 2010. PMID: 20215022

8

Denaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapy.

Benesova L, Pesek M, Belsanova B, Sekerka P, Minarik M. Benesova L, et al. Among authors: minarik m. J Sep Sci. 2010 Aug;33(15):2349-55. doi: 10.1002/jssc.201000124. J Sep Sci. 2010. PMID: 20574956

9

Multiplicity of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients treated with tyrosine kinase inhibitors.

Benesova L, Minarik M, Jancarikova D, Belsanova B, Pesek M. Benesova L, et al. Among authors: minarik m. Anticancer Res. 2010 May;30(5):1667-71. Anticancer Res. 2010. PMID: 20592359

10

A novel high-resolution chipCE assay for rapid detection of EGFR gene mutations and amplifications in lung cancer therapy by a combination of fragment analysis, denaturing CE and MLPA.

Minarik M, Gassman M, Belsanova B, Pesek M, Schouten J, Chudoba R, Gas B, Benesova L. Minarik M, et al. Electrophoresis. 2010 Oct;31(21):3518-24. doi: 10.1002/elps.201000156. Electrophoresis. 2010. PMID: 20967766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters